Anne N. Heirman

Anne N. Heirman

Auto-generated profile, based on publicly available information

Anne N. Heirman

Department of Otorhinolaryngology, Head and Neck Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute, Amsterdam, the Netherlands

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2024 in The Laryngoscope
Verified
Journal Article
Open access
AHAnne N. Heirman
Anne N. Heirman
DKDaan P. de Kort
Daan P. de Kort
JPJapke F. Petersen
Japke F. Petersen
AAAbrahim Al‐Mamgani
Abrahim Al‐Mamgani
SESimone E.J. Eerenstein
Simone E.J. Eerenstein
Michiel Van den BrekelMichiel Van den Brekel
Michiel Van den Brekel
Objectives: Decision‐making for patients with a locally advanced laryngeal carcinoma (T3 and T4) is challenging due to the treatment choice between organ preservation and laryngectomy, both with different and high impact on function and quality of life (QoL). The complexity of these treatment decisions and their possible consequences might lead to decisional conflict (DC). This study aimed to explore the level of DC in locally advanced laryngeal carcinoma patients facing curative decision‐making, and to identify possible associated factors.Methods: In this multicenter prospective cohort study, participants completed questionnaires on DC, level of shared decision‐making (SDM), and a knowledge test directly after counseling and 6 months after treatment. Descriptive statistics and Spearman correlation tests were used to analyze the data.Results: Directly after counseling, almost all participants (44/45; 98%) experienced Clinically Significant DC score (CSDC >25, scale 0–100). On average, patients scored 47% (SD 20%) correct on the knowledge test. Questions related to radiotherapy were answered best (69%, SD 29%), whilst only 35% (SD 29%) of the questions related to laryngectomy were answered correctly. Patients' perceived level of SDM (scale 0–100) was 70 (mean, SD 16.2), and for physicians this was 70 (SD 1.7).Conclusion: Most patients with advanced larynx cancer experience high levels of DC. Low knowledge levels regarding treatment aspects indicate a need for better patient counseling.Level of Evidence: 4 Laryngoscope, 134:3604–3610, 2024

4 March 2025 in Patient Education and Counseling
Verified
Journal Article
Open access
AHAnne N. Heirman
Anne N. Heirman
SDSong L.L. Duimel
Song L.L. Duimel
RTRoosmarijn S. Tellman
Roosmarijn S. Tellman
RDRichard Dirven
Richard Dirven
ALAnnemiek J. Linn
Annemiek J. Linn
Michiel Van den BrekelMichiel Van den Brekel
Michiel Van den Brekel
To explore the state of shared decision-making (SDM) in head and neck (HN) oncology by investigating the extent to which SDM is currently employed by HN surgeons and how the perceived levels of SDM relate to the observed levels of SDM. Additionally, surgeon and patient perspectives on patient involvement in SDM and potential associations with observed levels of SDM were explored. Perceived level of SDM and patient involvement were measured by SDM-Q-9/SDM-Q-Doc resp. Control Preference Scale. Observed SDM was measured by analyzing audiotaped consultations (N = 42) using the OPTIONmcc+ instrument. Univariate linear analyses were conducted to identify possible associations with surgeon-observed SDM. Median perceived SDM scores of surgeons (74.4 %) and patients (71.1 %) were relatively high, whereas observed median OPTION-scores were moderate (surgeons 48 %, patients 42 %, caregivers 24 %). Consultation time and patient OPTION-score were positively associated with surgeon OPTION-score. Surgeons and patients seem to overestimate the extent of SDM compared to the observed reality. Patients' goals, values and preferences need to be addressed more during consultations. The findings can be used to raise awareness of SDM among surgeons to improve their skills. Routine training in medical education can benefit from effective integration of SDM principles during consultations.

21 June 2023 in The Journal of Laryngology & Otology
Verified
Journal Article
Open access
PDF file
AHAnne N. Heirman
Anne N. Heirman
WGWim G. Groen
Wim G. Groen
LMLisette van der Molen
Lisette van der Molen
RDRichard Dirven
Richard Dirven
MBMichiel W.M. van Den Brekel
Michiel W.M. van Den Brekel
MSMartijn M Stuiver
Martijn M Stuiver
Objective: After laryngectomy, the breathing resistance of heat and moisture exchangers may limit exercise capacity. Breathing gas analysis during cardiopulmonary exercise testing is not possible using regular masks. This study tested the feasibility of cardiopulmonary exercise testing with a heat and moisture exchanger in situ, using an in-house designed connector. Additionally, we explored the effect of different heat and moisture exchanger resistances on exercise capacity in this group.Methods: Ten participants underwent two cardiopulmonary exercise tests using their daily life heat and moisture exchanger (0.3 hPa or 0.6 hPa) and one specifically developed for activity (0.15 hPa). Heat and moisture exchanger order was randomised and blinded.Results: All participants completed both tests. No (serious) adverse events occurred. Only four subjects reached a respiratory exchange ratio of more than 1.1 in at least one test. Maximum exercise levels using heat and moisture exchangers with different resistances did not differ.Conclusion: Cardiopulmonary exercise testing in laryngectomees with a heat and moisture exchanger is feasible; however, the protocol does not seem appropriate to reach this group's maximal exercise capacity. Lowering heat and moisture exchanger resistance does not increase exercise capacity in this sample.

14 August 2023 in Acta Oto-Laryngologica
Verified
Journal Article
Open access
AHAnne N. Heirman
Anne N. Heirman
RTRoosmarijn Sophie Tellman
Roosmarijn Sophie Tellman
LMLisette van der Molen
Lisette van der Molen
RSRob van Son
Rob van Son
KSKlaske van Sluis
Klaske van Sluis
RDRichard Dirven
Richard Dirven
Background: The Provox Vega High Performance (PVHP) is a newly developed voice prosthesis (VP) with an aim to achieve a longer and more predictable lifetime. Objectives: This feasibility study aims to assess patient acceptance of the PVHP VP, evaluate adverse events, voice quality, and device lifetime. Methods: Laryngectomized patients previously using a Provox Vega or ActiValve Light were included. Acceptance and voice outcomes were evaluated at two-time points with a 2-week interval. Baseline measurements were taken with the standard VP, followed by placement of the PVHP for the 2-week assessment. Results: Fifteen participants completed the study, with thirteen being initial Vega-users. PVHP acceptance was 87% 2 weeks after placement. Median device lifetime for all VPs was 64 d (range 14-370). In the subgroup without periprosthetic leakage, the median device lifetime was 101 d (range 31-370). Acceptance dropped to 40% after device failure. Voice quality did not differ between PVHP and baseline VP. The most reported adverse event was PVHP valve stickiness (46%). Conclusion and significance: Acceptance of the PVHP is largely dependent on device lifetime, decreasing from 87% to 40% after leakage or replacement. Voice quality remains consistent across different VPs. Developing a long-lasting VP remains a challenge.

22 December 2023 in Oral Oncology
Verified
Journal Article
Open access
AHAnne N. Heirman
Anne N. Heirman
RDRichard Dirven
Richard Dirven
LMLisette van der Molen
Lisette van der Molen
WSWillem H. Schreuder
Willem H. Schreuder
FHFrank Hoebers
Frank Hoebers
Michiel Van den BrekelMichiel Van den Brekel
Michiel Van den Brekel
The aim of this project is to create an interactive online patient decision aid (PDA) for oropharyngeal cancer (OPSCC) patients, eligible for transoral (robotic) surgery with an ultimate goal to assist both physicians and patients in making treatment choices. Following the International Patient Decision Aid Standards, a mixed-methods approach was employed. The study involved semi-structured in-depth interviews with patients and physicians, thinking-out-loud sessions, and study-specific questionnaires. Thematic coding and analysis were conducted on verbatim transcriptions of audio-recorded interviews. The PDA drafts were evaluated by twenty OPSCC survivors and twenty multidisciplinary specialists. Significant revisions were made after phase 1 to enhance readability and reduce text, whilst incorporating videos and graphics. Following all phases, both patients and specialists rated the PDA as comprehensible, feasible, and a valuable addition to regular counseling. This study showcases the development of a PDA for early stage oropharyngeal cancer patients considering surgery and radiotherapy options. The decision aid emphasizes the disparities in short- and long-term side effects between the two treatments. Patients and physicians found the decision aid to be understandable, user-friendly, and helpful for future patients. The PDA is available on https://beslissamen.nl/.

20 June 2026 in Patient Education and Counseling
Verified
Journal Article
Open access
ATAntje Lena Timmer
Antje Lena Timmer
AHAnne N. Heirman
Anne N. Heirman
SDSong L.L. Duimel
Song L.L. Duimel
Sebastiaan de VisscherSebastiaan de Visscher
Sebastiaan de Visscher
Michiel Van den BrekelMichiel Van den Brekel
Michiel Van den Brekel
SFSuzanne Festen
Suzanne Festen
Decision-making with patients with head and neck cancer is complex due to their vulnerability, even at a young age, and the intensity of the treatment. Discussing patient goals, values and preferences is crucial for tailoring treatment and patient-centered care, especially given the high levels of decisional conflict and regret among this patient group. This study aimed to explore whether, how, and which patient goals were discussed during treatment decision-making consultations and how surgeons responded to these goals. This study is a secondary analysis of a cross-sectional study. A qualitative content analysis was performed on transcripts from audio recordings of treatment decision-making consultations between patients and surgeons at the head and neck cancer outpatient clinic from two tertiary centers in the Netherlands. Goals or goal-related cues were identified utilizing the three-goal model by Vermunt and the health outcomes of the Outcome Prioritization Tool. Sixty-six transcripts were analyzed, corresponding to 66 patients and nine head and neck surgeons. In 11 consultations, no goals were mentioned. In the remaining 55 consultations, goals were most often mentioned by patients or their relatives, usually implicit and often due to concerns or fears. In one consultation goals were elicited by the surgeon. The most frequently mentioned goals were related to life extension, functional outcomes, or symptom-specific issues. Surgeons typically responded to goals with 'medical-technical' explanations about treatment or disease. Patient goals were not routinely discussed during decision-making with head and neck cancer patients. When mentioned, the initiative often came from the patient or their relatives. Surgeons regularly responded with a medical technical explanation, and the underlying considerations or concerns of the patient were often not further explored. This can be considered a missed opportunity to discuss patient goals and for personalized care.